The following are the 11 national institutes under AYUSH established to promote excellence in ISM and Homeopathy education:

1. National Institute of Ayurveda, Jaipur
2. National Institute of Siddha, Chennai
3. National Institute of Unani Medicine, Bengaluru
4. Morarji Desai National Institute of Yoga, New Delhi
5. National Institute of Naturopathy, Pune
6. National Institute of Homeopathy, Kolkata
7. The Rashtriya Ayurveda Vidyapeeth, Delhi
8. The All India Institute of Ayurveda, New Delhi
9. North Eastern Institute of Folk Medicine, Pasighat.
10. Institute of Post Graduate Teaching and Research in Ayurveda, Jamnagar
11. North Eastern Institute of Ayurveda and Homeopathy, Shillong.

National Medicinal Plant Board (NMPB)

Medicinal plants are a living resource, exhaustible if overused and sustainable if used with care and wisdom. They are not only a resource base for the traditional medicine and herbal industry but also provide livelihood and health security to a large segment of the Indian population. About 960 species of medicinal plants are estimated to be in trade of which 178 species have annual consumption levels in excess of 100 metric tonnes. Domestic trade of the AYUSH industry is of the order of Rs. 80–90 billion. India at present exports herbal materials and medicines to the tune of Rs.1,000 crores only while it has been estimated that this can be raised to Rs. 12,000 crores by 2012. World trade in herbal products being US $120 billion, it is expected to reach US $7 trillion by 2050. The Chinese export based on plants including raw drugs, therapeutics and other is estimated to be around Rs. 18,000–Rs. 22,000 crores. In view of the innate Indian strengths which inter alia include diverse ecosystems, technical and farming capacity and a strong manufacturing sector, the medicinal plants area can become a huge export opportunity after fulfilling domestic needs.

Apart from requirement of medicinal plants for internal consumption, India exports crude drugs mainly to developed countries, namely the United States, Germany, France, Switzerland, UK and Japan, who share between them 75% to 80% of the total export of crude drugs from India. Medicinal plants market in the country is today unorganized due to several problems that affect it directly and indirectly.

1. At present 95% collection of medicinal plants is from the wild. Current practices of harvesting are unsustainable and many studies have highlighted depletion of resource base.
2. Pharmaceutical companies are partly responsible for inefficient, imperfect, informal and opportunistic marketing of medicinal plants.
3. There is a vast, secretive and largely unregulated trade in medicinal plants, mainly from the wild, which continues to grow dramatically in the absence of serious policy attention with environmental planning.
4. Confusion also exists in the identification of plant material where the origin of a particular drug is assigned to more than one plant, leading to adulteration in such cases.
5. Marketing is a daunting problem, since marketability of products is a crucial factor in determining the success of a product.

A clear understanding of both supply-related issues and the factors driving the demand and size of the medicinal plants market is vital. This will ensure both the conservation and sustainable use of the habitats of these plants as well as ensure continued availability of the basic ingredients.

The medicinal plant board was set up under a government resolution to establish an agency which would be responsible for coordination of all matters relating to medicinal plants, including drawing up policies and strategies for conservation, proper harvesting, cost-effective cultivation, research and development, processing, marketing of raw material in order to protect, sustain and develop this sector.